ADC Therapeutics (ADCT) Inventory: 2021-2023
Historic Inventory for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $22.7 million.
- ADC Therapeutics' Inventory rose 44.35% to $22.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $22.7 million, marking a year-over-year increase of 44.35%. This contributed to the annual value of $12.1 million for FY2022, which is 8.55% up from last year.
- According to the latest figures from Q3 2023, ADC Therapeutics' Inventory is $22.7 million, which was up 16.99% from $19.4 million recorded in Q2 2023.
- Over the past 5 years, ADC Therapeutics' Inventory peaked at $22.7 million during Q3 2023, and registered a low of $7,718 during Q2 2021.
- For the 3-year period, ADC Therapeutics' Inventory averaged around $11.4 million, with its median value being $13.4 million (2022).
- Data for ADC Therapeutics' Inventory shows a peak YoY soared of 196,515.88% (in 2022) over the last 5 years.
- Quarterly analysis of 3 years shows ADC Therapeutics' Inventory stood at $11.1 million in 2021, then climbed by 8.55% to $12.1 million in 2022, then spiked by 44.35% to $22.7 million in 2023.
- Its Inventory was $22.7 million in Q3 2023, compared to $19.4 million in Q2 2023 and $18.2 million in Q1 2023.